BiondVax Pharma: In Vivo Data Shows NanoAb Virtually Prevents COVID-19 In Hamsters
(RTTNews) - BiondVax Pharmaceuticals Ltd. (BVXV) announced additional results in a preclinical proof-of-concept study of its inhaled NanoAb COVID-...
Source: businessinsider.com